Periscope Capital’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,500
| Closed | -$22.5K | – | 410 |
|
|
2024
Q1 | $22.5K | Sell |
15,500
-134,500
| -90% | -$195K | 0.01% | 280 |
|
|
2023
Q4 | $13.5K | Hold |
150,000
| – | – | ﹤0.01% | 367 |
|
|
2023
Q3 | $22.5K | Sell |
150,000
-342,330
| -70% | -$51.4K | ﹤0.01% | 451 |
|
|
2023
Q2 | $44.3K | Sell |
492,330
-25,500
| -5% | -$2.3K | ﹤0.01% | 439 |
|
|
2023
Q1 | $28.5K | Buy |
517,830
+82,566
| +19% | +$4.54K | ﹤0.01% | 615 |
|
|
2022
Q4 | $19.8K | Hold |
435,264
| – | – | ﹤0.01% | 685 |
|
|
2022
Q3 | $32K | Buy |
435,264
+166,864
| +62% | +$12.3K | ﹤0.01% | 781 |
|
|
2022
Q2 | $40K | Buy |
268,400
+16,600
| +7% | +$2.47K | ﹤0.01% | 742 |
|
|
2022
Q1 | $79K | Hold |
251,800
| – | – | ﹤0.01% | 822 |
|
|
2021
Q4 | $129K | Buy |
251,800
+85,500
| +51% | +$43.8K | ﹤0.01% | 776 |
|
|
2021
Q3 | $97K | Hold |
166,300
| – | – | ﹤0.01% | 781 |
|
|
2021
Q2 | $167K | Buy |
+166,300
| New | +$167K | 0.01% | 632 |
|